Actively Recruiting

Phase Not Applicable
Age: 6Years - 18Years
All Genders
Healthy Volunteers
NCT07522528

Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study

Led by University of Glasgow · Updated on 2026-04-13

90

Participants Needed

6

Research Sites

226 weeks

Total Duration

On this page

Sponsors

U

University of Glasgow

Lead Sponsor

N

NHS Greater Clyde and Glasgow

Collaborating Sponsor

AI-Summary

What this Trial Is About

Crohn's disease (CD) is a chronic, incurable condition associated with gut inflammation. Two important treatments currently used to manage CD are special drug injections (biologics) or a liquid-only diet using specialised milkshakes. However, treatment with biologics is only successful in approximately 55-60%. The liquid-only diet also has a better safety and effectiveness profile than traditional treatments like steroids. However, gut inflammation often returns not long after the normal diet is re-introduced, and it is difficult for patients to stick to as their sole source of nutrition for 6-8 weeks. The BIOPIC-Kids study aims to investigate whether replacing the normal diet with specialised milkshakes for 6 weeks improves response to treatment and maintenance of remission with biologics in children and young adults with CD. To achieve this, children and young adults (aged 6-18 years) with active CD commencing biologics as standard of care treatment will be randomly allocated to follow their normal diet OR replace varying amounts of their normal diet with specialised milkshakes for 6 weeks. Participants not wanting to be randomised can choose the group of their preference. Patients starting a liquid-only diet OR biologics alongside a liquid-only diet as standard of care treatment will also be recruited to compare different treatment outcomes.

CONDITIONS

Official Title

Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study

Who Can Participate

Age: 6Years - 18Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Children or young adults aged 6 to 18 years with active Crohn's disease defined by a weighted paediatric Crohn's Disease Activity Index score 212.5 or faecal calprotectin level over 250 mg/kg
  • Clinical indication to start standard induction treatment with TNF alpha inhibitors infliximab or adalimumab
  • For observational groups, children or young adults aged 6 to 18 years with active Crohn's disease starting exclusive enteral nutrition therapy with or without TNF alpha inhibitors
Not Eligible

You will not qualify if you...

  • Unable to provide consent to participate (including young adults aged 16-18 unable to consent or carers unable to consent for children aged 6-15)
  • Presence of stoma or short bowel syndrome
  • Currently taking oral or intravenous steroids above 20mg/day prednisolone or 9mg/day budesonide
  • Started another induction therapy or changed immunomodulator dose within past 4 weeks
  • Crohn's disease with major fistulising or symptomatic fibrotic stricturing phenotype
  • Comorbid anorexia nervosa
  • Clinical contraindication to exclusive or partial enteral nutrition
  • Positive test for blood-borne viruses such as HIV or Hepatitis B or C
  • Untreated latent or active tuberculosis
  • Currently enrolled in other studies involving investigational products or dietary interventions
  • Food allergies preventing participation (e.g., cow's milk allergy)
  • Pregnant or breastfeeding individuals

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

The Royal Aberdeen Children's Hospital

Aberdeen, United Kingdom, AB25 2ZG

Not Yet Recruiting

2

University Hospital Crosshouse

Crosshouse, United Kingdom, KA2 0BE

Not Yet Recruiting

3

Ninewells Hospital

Dundee, United Kingdom, DD1 9SY

Not Yet Recruiting

4

Royal Hospital for Children & Young People

Edinburgh, United Kingdom, EH16 4TJ

Actively Recruiting

5

Royal Hospital For Children

Glasgow, United Kingdom, G51 4TF

Actively Recruiting

6

University Hospital Wishaw

Wishaw, United Kingdom, ML2 0DP

Not Yet Recruiting

Loading map...

Research Team

K

Konstantinos Gerasimidis, Professor

CONTACT

S

Sophie F Morris, BSc (Hons)

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here